Health Care · Laboratory Analytical Instruments

ILMN Illumina Inc SEC Filings & Insider Trading Activity 2026

company
CIK 111080399 filings

ILMN at a glance

Illumina Inc (ILMN, SEC CIK 1110803) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on October 30, 2026, an 8-K current report on October 29, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 28, 2025 (FY2025), Illumina Inc (ILMN) reported revenue of $4.3 billion (down 0.7% from FY2024) and net income of $850.0 million. Diluted EPS was $5.45.
  • As of September 30, 2026, 44 institutional investment managers tracked by SignalX reported holding Illumina Inc (ILMN) shares worth $17.2 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Meister Keith A. on November 11, 2026 of 12,305 shares at $219.55 per share.
  • In the last 90 days, ILMN insiders reported 0 open-market purchases ($0) and 60 open-market sales ($270.2M) on Form 4, a net sale of $270.2M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$4.3B
−0.7% vs prior year
Insiders · 90 days
0 buys · 60 sells
Net −$270.2M
13F holders
44 funds
$17.2B · −1 vs prior quarter
Latest 8-K
Oct 29, 2026
Item 2.02

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Oct 29, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q3 revenue $1.13B, up 4.2%; underlying revenue excluding tariff refunds $1.17B, up 4.7%
  • GAAP operating margin 27.0% versus 21.0%; non-GAAP margin excluding tariff refunds 25.0%

Item 2.02: Results of Operations and Financial Condition

  • Q3 fiscal 2026 financial results announced for quarter ended September 27, 2026
  • Full results and management commentary available in Exhibit 99.1
Filed Oct 13, 2026Full analysis →

Item 1.01: Entry into a Material Definitive Agreement

  • $1.0 billion unsecured commercial paper capacity, enabling flexible short-term funding
  • No commercial paper outstanding as of October 8, 2026, so no immediate borrowing or interest burden

Item 2.03: Creation of a Direct Financial Obligation

  • Item 2.03 contains no standalone obligation details
  • Financial obligation terms require review of the referenced Item 1.01 agreement
Filed Aug 17, 2026Full analysis →

Item 8.01: Other Events

  • $300 million issued in 4.950% notes maturing September 19, 2029
  • Semiannual interest payments create approximately $14.85 million annual interest expense

AI summaries of ILMN 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for ILMN

Don't miss the next ILMN filing

  • Alerts as it files. A push when ILMN files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut ILMN, by share count.
  • Ask anything. An AI agent that reads every ILMN filing and answers with sources.

ILMN alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Meister Keith A.SellNov 11, 2026$219.55
Meister Keith A.SellNov 11, 2026$221.09
Meister Keith A.SellNov 11, 2026$216.64
Meister Keith A.SellNov 11, 2026$218.50
Meister Keith A.SellNov 11, 2026$214.02
Meister Keith A.SellNov 11, 2026$220.45
Meister Keith A.SellNov 11, 2026$212.97
Meister Keith A.SellNov 11, 2026$215.48

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$4.4B$4.3B
Gross Profit-$2.9B$2.9B
Operating Income--$833.0M$807.0M
Net Income--$1.2B$850.0M
Gross Margin-65.4%66.1%
Op. Margin--19.1%18.6%
Net Margin--28.0%19.6%
Balance Sheet
Total Assets$10.1B$6.3B$6.6B
Equity$5.7B$2.4B$2.7B
ROE--51.5%31.2%
Per Share
EPS-$-7.69$5.45
Cash Flow
Operating CF-$837.0M$1.1B
CapEx-$128.0M$148.0M

Source: XBRL data in Illumina Inc (ILMN)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate ILMN share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
ILMN shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202644$17.16B
Q2 202645$11.15B
Q1 202640$7.59B
Q4 202538$8.34B
Q3 202539$5.86B
Q2 202537$5.91B
Q1 202533$3.18B
Q4 202431$4.71B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers

Source: 13F-HR filings on SEC EDGAR (aggregated from 307 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

ILMN filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 5, 2026--
10-QOct 30, 2026-
8-KOct 29, 2026Analysis-
8-KOct 13, 2026Analysis-
4Oct 7, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Sep 10, 2026--
4Sep 9, 2026--
4Sep 4, 2026--
4Aug 27, 2026--
4Aug 21, 2026--
4Aug 20, 2026--
8-KAug 17, 2026Analysis-
8-KAug 13, 2026Analysis-
8-KAug 12, 2026Analysis-
4Aug 7, 2026--
8-KAug 7, 2026Analysis-
4Aug 6, 2026--

Related Health Care companies

All Health Care →

ILMN SEC filings: frequently asked questions

Are ILMN insiders buying or selling?

In the last 90 days, Illumina Inc (ILMN) officers, directors and 10% owners reported no open-market purchases and 60 open-market sales worth $270.2 million by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold ILMN stock?

As of September 30, 2026, the largest Illumina Inc (ILMN) holders among the 13F filers tracked by SignalX were BlackRock ($4.3 billion), Vanguard Capital Management LLC ($2.7 billion), State Street Corp ($2.0 billion), Vanguard Portfolio Management LLC ($1.7 billion), JPMorgan Chase & Co ($1.3 billion). 13F-HR reports are filed up to 45 days after each quarter ends.

What was ILMN's revenue in fiscal year 2025?

For the fiscal year ended December 28, 2025 (FY2025), Illumina Inc (ILMN) reported revenue of $4.3 billion (down 0.7% from FY2024) and net income of $850.0 million. Diluted EPS was $5.45. The figures come from the XBRL data in the 10-K.

What did ILMN report in its latest 8-K?

Illumina Inc (ILMN) filed an 8-K on October 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 revenue $1.13B, up 4.2%; underlying revenue excluding tariff refunds $1.17B, up 4.7%.

What are the latest ILMN SEC filings?

Illumina Inc (ILMN) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on October 30, 2026, an 8-K current report on October 29, 2026 and a Form 4 insider filing on November 12, 2026.

What is ILMN's SEC CIK number?

Illumina Inc (ILMN)'s SEC Central Index Key (CIK) is 1110803. EDGAR lists every ILMN filing under that number.

Ask anything about ILMN

The research agent reads ILMN's filings, financials, insider trades and 13F holders, then answers with sources.